Intraperitoneal chromic phosphate P 32 as salvage therapy for persistent carcinoma of the ovary after surgical restaging
- 1 May 1987
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 156 (5) , 1153-1158
- https://doi.org/10.1016/0002-9378(87)90131-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Second-look laparotomy after chemotherapy in the management of ovarian malignancyAmerican Journal of Obstetrics and Gynecology, 1985
- Microscopic disease at second-look laparotomy in advanced ovarian cancerCancer, 1985
- Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation)American Journal of Obstetrics and Gynecology, 1983
- The use of intravenous phenylalanine mustard followed by supervoltage irradiation in the treatment of carcinoma of the ovaryCancer, 1983
- Observations on the intraperitoneal distribution of chromic phosphate (32P) suspension for intraperitoneal therapy.Radiology, 1983
- Radioactive chromic phosphate suspension: Studies on distribution, dose absorption, and effective therapeutic radiation in phantoms, dogs, and patientsGynecologic Oncology, 1981
- Second-look operations in ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1980
- Ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1979
- Sequential therapy for advanced ovarian adenocarcinoma: Operation, chemotherapy, second-look laparotomy, and radiation therapyAmerican Journal of Obstetrics and Gynecology, 1975
- A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorshipBiometrika, 1970